Research Article

Molecular Mechanism of Crataegi Folium and Alisma Rhizoma in the Treatment of Dyslipidemia Based on Network Pharmacology and Molecular Docking

Table 4

The binding ability between active components and core targets.

TargetActive compoundStructure identifierTotal scoreCrashPolarCs score

CCND1Quercetin2W965.1903−1.07174.18854
CASP3Quercetin1NMS4.9902−0.8822.87754
Kaempferol1NMS5.2574−1.03013.05975
HIF1AQuercetin6GMR6.6632−1.71086.74775
ESR1Isorhamnetin1L2I6.7808−2.14813.31455
Ent-epicatechin1L2I5.5575−1.83044.35915
ERBB2Quercetin1MFG4.5064−0.41284.44255
MYCQuercetin1NKP6.3422−0.80112.22384
PTENQuercetin1D5R4.2476−1.09263.52415
TP53Quercetin1AIE4.3401−0.98612.72295
AKT1Quercetin1UNQ5.0166−0.71644.86845
Kaempferol1UNQ5.0044−0.66814.8723
EGFRQuercetin1XKK5.7674−0.38371.89074